Biolinq External Interferent Protocol
NCT06560177
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
31
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes
Diabetes Mellitus
Interventions
DEVICE:
The Biolinq MicroArray Intradermal Continuous Glucose Biowearable System
Sponsor
Biolinq Inc.